tiziana-logo.png
Tiziana Life Sciences Ltd. To Implement Stock Repurchase Program for up to $5 Million
January 24, 2022 11:12 ET | Tiziana Life Sciences Ltd.
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock...
tiziana-logo.png
Tiziana Life Sciences Announces Death of Director
January 13, 2022 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today...
tiziana-logo.png
Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis
January 10, 2022 07:00 ET | Tiziana Life Sciences Ltd.
- Clinical data from the first patient, after completing 3 out of 6 months, suggest that the treatment was well tolerated with a favorable clinical response - FDA allows for continued enrollment...
tiziana-logo.png
Tiziana Life Sciences to Participate in 2022 Biotech Showcase Virtual Investor Conference
January 06, 2022 16:15 ET | Tiziana Life Sciences Plc
NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today...
tiziana-logo.png
Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQ
October 21, 2021 02:00 ET | Tiziana Life Sciences Plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS...
tiziana-logo.png
Tiziana Life Sciences - Scheme Effective Date
October 20, 2021 09:40 ET | Tiziana Life Sciences Plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS...
tiziana-logo.png
Tiziana Life Sciences plc: PDMR Dealing
October 20, 2021 02:00 ET | Tiziana Life Sciences Plc
LONDON and NEW YORK, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
tiziana-logo.png
Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capital
October 19, 2021 09:26 ET | Tiziana Life Sciences Plc
LONDON and NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Old Tiziana") a biotechnology company focused on innovative therapeutics for oncology,...
tiziana-logo.png
Tiziana Life Sciences plc: PDMR Dealing
September 28, 2021 04:19 ET | Tiziana Life Sciences Plc
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
tiziana-logo.png
Tiziana Life Sciences Plc - Results of Court Meeting and General Meeting
September 27, 2021 12:39 ET | Tiziana Life Sciences Plc
LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- On 20 August 2021, Tiziana Life Sciences Plc (“Old Tiziana”) announced that it has formally commenced its strategic plan to change its corporate structure...